Notably, a 2022 study revealed that ELOVL2 is significantly upregulated in PCa compared to normal prostate tissue and regulates cancer cell behavior through INPP4B signaling, further underscoring its importance in PCa progression (Hu et al., 2022). The gene discussed is INPP4B; the disease is cancer.